Study 13 of 774 for search of: "Stroke"
Previous Study Return to Search Results Next Study

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Clinic-Based AMES Treatment of Stroke
This study is currently recruiting participants.
Verified by AMES Technology, December 2008
Sponsors and Collaborators: AMES Technology
Oregon Health and Science University
Information provided by: AMES Technology
ClinicalTrials.gov Identifier: NCT00600184
  Purpose

The AMES device a investigational device which cyclically rotates the ankle while muscle vibrators stimulate sensory receptors in the muscles opposite to the joint being rotated. In effect, the device provides assisted movement of a joint and enhanced sensation of that movement. The purpose of this study is to determine whether stroke survivors who remain unable to move normally more than one year after their stroke will be able to walk and move their affected leg significantly better after treatment with a new robotic therapy, the AMES device.


Condition Intervention Phase
Stroke
Cerebrovascular Accident
Device: The AMES device
Phase I
Phase II

U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title: Clinic-Based Assisted Movement and Enhanced Sensation Treatment of Stroke

Further study details as provided by AMES Technology:

Primary Outcome Measures:
  • Fugl-Meyer Assessment of the Lower Extremity [ Time Frame: Pre-treatment, Post-treatment ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Gait Assessment [ Time Frame: Pre-treatment, Post-treatment ] [ Designated as safety issue: No ]
  • Stroke Impact Scale [ Time Frame: Pre-treatment, Post-treatment ] [ Designated as safety issue: No ]
  • Spasticity (Modified Ashworth) Scale [ Time Frame: Pre-treatment, Post-treatment ] [ Designated as safety issue: No ]
  • Biodex Isokinetic Strength Measurements [ Time Frame: Pre-treatment, Post-treatment ] [ Designated as safety issue: No ]
  • Strength Test [ Time Frame: Prior to each treatment session ] [ Designated as safety issue: No ]
  • Joint Position Test [ Time Frame: Prior to each treatment session ] [ Designated as safety issue: No ]
  • Passive Motion Test [ Time Frame: Prior to each treatment session ] [ Designated as safety issue: No ]

Estimated Enrollment: 16
Study Start Date: January 2008
Estimated Study Completion Date: June 2009
Estimated Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
One: Experimental Device: The AMES device
The AMES device is a investigational device which cyclically rotates the ankle while muscle vibrators stimulate sensory receptors in the muscles opposite to the joint being rotated. Each subject will be tested before and after the 10-week treatment period. Treatment sessions will occur 3 times per week and last approximately 30 minutes per treatment. The device will measure 3 of the functional tests prior to each treatment session.

Detailed Description:

Each year, more that 600,000 U.S. citizens survive a major stroke. Following acute treatment, 30-40% of these survivors sustain permanent motor disabilities. Within weeks of the stroke, surviving patients begin physical therapy to restore motion to affected limbs. Some recover completely, but many do not. There are over 5 million stroke survivors in the U.S. who did not recover completely and many are severely incapacitated for the remainder of their lives.

The hypothesis underlying stroke rehabilitation with AMES is that, in many stroke victims, the damage to the brain disrupts one or more feedback loops that connect the proprioceptive receiving areas of the primary somatosensory cortex to the primary and pre-motor cortex. Without proprioceptive information feeding into the motor output center, the brain cannot "locate" the muscles needed for movement to occur. The hypothesis behind AMES rehabilitation is that synchronous and repetitive activity of the input and output areas of the cortex stimulate the reorganization of brain pathways, thereby closing the feedback loop disrupted by the stroke.

Our research objective is to develop procedures to rehabilitate those stroke patients who, through conventional therapies, were not brought to a level of maximal recovery. The aim of the study is to obtain a set of data from a total of 16 chronic stroke subjects, all with lower extremity disability, between the ages of 18-75, using the AMES robotic device in a rehabilitation clinic. Each subject will participate in 10 weeks of therapy, 3 days per week, 30 minutes per day. The data collected will be analysed to quantify the extent to which a combination of robot-assisted exercise and muscle vibration induce secondary recovery from stroke in the lower extremity.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • At least 12 months post-stroke
  • Cognitively and behaviorally capable of complying with the regimen
  • Functioning proprioception
  • Less than 50% of normal strength in the affected ankle, but able to stand with ot without assistive devices

Exclusion Criteria:

  • Fractures of treated limb resulting in loss of range of motion
  • Spinal cord injury
  • Deep vein thrombosis
  • Peripheral nerve injury or neuropathy in the affected limb with motor disability
  • Osteoarthritis limiting range of motion
  • Skin condition not tolerant of device
  • Progressive neurodegenerative disorder
  • Uncontrolled seizure disorder
  • Botox treatment within the last 5 months
  • Baclofen pump
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00600184

Contacts
Contact: Linda D. Cordo, BS MSN 503-223-3442 cordol@ohsu.edu

Locations
United States, Oregon
Oregon Health and Science University Center for Health and Healing Recruiting
Portland, Oregon, United States, 97201
Contact: Linda D. Cordo, BS MSN     503-223-3442     cordol@ohsu.edu    
Contact: Paul J. Cordo, PhD     503-970-6129     cordop@ohsu.edu    
Sub-Investigator: Helmi Lutsep, MD            
Sub-Investigator: Connie Amos, MSCCC SLP            
Sub-Investigator: Jennifer Wilhelm, DPT            
Sponsors and Collaborators
AMES Technology
Oregon Health and Science University
Investigators
Principal Investigator: Paul J. Cordo, PhD AMES Technology Inc./ Oregon Health and Science University
  More Information

Related Info  This link exits the ClinicalTrials.gov site

Responsible Party: AMES Technology, Inc./ Oregon Health and Science University ( Paul J. Cordo/Principal Investigator )
Study ID Numbers: CT002, IRB00004005
Study First Received: December 31, 2007
Last Updated: December 10, 2008
ClinicalTrials.gov Identifier: NCT00600184  
Health Authority: United States: Institutional Review Board

Keywords provided by AMES Technology:
Stroke
Rehabilitation
Robotics

Study placed in the following topic categories:
Cerebral Infarction
Stroke
Vascular Diseases
Central Nervous System Diseases
Brain Ischemia
Ischemia
Brain Infarction
Brain Diseases
Infarction
Cerebrovascular Disorders

Additional relevant MeSH terms:
Nervous System Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009